Study highlights 'worrying' increase in misuse of non-opioid medications
(Taylor& Francis Group) A major new analysis of the non-opioid medications, gabapentin and baclofen, shows 'worrying' increases in related suicide attempts and hospital admissions in US adults since 2013 -- coinciding with a decrease in opioid prescriptions. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 2, 2019 Category: International Medicine & Public Health Source Type: news
New opioid library unveiled to help address epidemic
(Oregon Health& Science University) A new curated library provides a centralized toolkit for policymakers, patients and health care professionals working to address the nation's opioid epidemic. The site, funded through a settlement agreement involving the off-label marketing of the pain medication Neurontin, provides a single clearinghouse of actionable, evidence-based resources to address the epidemic. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 20, 2019 Category: International Medicine & Public Health Source Type: news
Early ID of prenatal exposure to opioids, gabapentin improves timely treatment of newborns
(Marshall University Joan C. Edwards School of Medicine) Timely identification of newborns exposed to both opioids and gabapentin during pregnancy could mean more appropriate care for newborns experiencing withdrawal. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2019 Category: International Medicine & Public Health Source Type: news
Steep Jump in Gabapentinoid Use Among US Patients With Cancer Steep Jump in Gabapentinoid Use Among US Patients With Cancer
The use of gabapentin and pregabalin doubled between 2005 and 2015 among US patients with cancer; experts say these drugs may be appropriate, but warn about adverse effects and potential for abuse.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 7, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Prescriptions for dangerously addictive opioids have almost DOUBLED in the past five years
There has been an 80 per cent increase in the number of prescriptions for powerful nerve drug gabapentin in England since 2013, a study has found. (Source: the Mail online | Health)
Source: the Mail online | Health - September 17, 2019 Category: Consumer Health News Source Type: news
Dishing out more drugs won ’t stop the pain. Doctors need new tools | Ann Robinson
As a GP, I know opioids have their place. But we shouldn ’t be complacent about a US-style crisis happening in BritainGrowing concern about the prescription of drugs that cause dependence has been backed up by a recent report from Public Health England (PHE). The agencydiscovered that in 2017-18, 13% of adults in England received at least one prescription for opioids such as morphine or oxycodone (although this represented a slight downturn in prescribing after a long upward trend). Other drug classes were implicated too, with 25% of adults prescribed one or more of the following drugs: benzodiazepines (such as Valium), ...
Source: Guardian Unlimited Science - September 15, 2019 Category: Science Authors: Ann Robinson Tags: Opioids GPs NHS Doctors Health Society Drugs policy Politics Science UK news Source Type: news
gabapentin (Gralise) vs. duloxetine (Cymbalta)
Title: gabapentin (Gralise) vs. duloxetine (Cymbalta)Category: MedicationsCreated: 7/22/2019 12:00:00 AMLast Editorial Review: 7/22/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 22, 2019 Category: Drugs & Pharmacology Source Type: news
Industry Money Fuels Gabapentin Prescribing Industry Money Fuels Gabapentin Prescribing
Physicians who receive payments from makers of brand-name gabapentinoids are almost twice as likely to prescribe the brand-name agents vs generic versions, new research suggests.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - July 10, 2019 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news
More money, more gabapentin
Pharmaceutical companies' payments to doctors may be influencing them to prescribe more expensive, brand-name versions of the pain drug gabapentin, a team of researchers report in the July 8 issue of JAMA Internal Medicine, and the increasing use of the drug suggests it may be being abused. (Source: World Pharma News)
Source: World Pharma News - July 9, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Prescription rates for a painkiller linked to suicide TRIPLED as doctors received more kickbacks
Gabapentin is popular among US doctors because it doesn't interact with other drugs and it doesn't trigger a rush of ecstasy like other drugs. But it does have dangerous side effects. (Source: the Mail online | Health)
Source: the Mail online | Health - July 8, 2019 Category: Consumer Health News Source Type: news
DR ELLIE CANNON: My big toe pain is a huge problem
A 73-year-old patient has written to DR ELLIE CANNON about arthritis in her foot which is keeping her up at night. Her doctor has prescribed her a drug called gabapentin, but she's reluctant to take it. (Source: the Mail online | Health)
Source: the Mail online | Health - July 6, 2019 Category: Consumer Health News Source Type: news
Gabapentinoids used Off-label for Pain: Effective or Erroneous?
Off-label gabapentin and pregabalin prescribing for pain is widespread; the opioid crisis may be to blame. But does science support the trend? Find out with these 10 questions. (Source: ConsultantLive)
Source: ConsultantLive - June 21, 2019 Category: Internal Medicine Authors: Steven A. King, MD, MS Tags: Pain Source Type: news
Millions Take Gabapentin for Pain. But There ’s Scant Evidence It Works.
“There is very little data to justify how these drugs are being used and why they should be in the top 10 in sales,” a researcher said. (Source: NYT Health)
Source: NYT Health - May 20, 2019 Category: Consumer Health News Authors: Jane E. Brody Tags: Drugs (Pharmaceuticals) Gabapentin (Drug) Opioids and Opiates Neurontin (Drug) Drug Abuse and Traffic Pain-Relieving Drugs Source Type: news
Personal Health: Millions Take Gabapentin for Pain. But There ’ s Scant Evidence It Works.
“ There is very little data to justify how these drugs are being used and why they should be in the top 10 in sales, ” a researcher said. (Source: NYT Health)
Source: NYT Health - May 20, 2019 Category: Consumer Health News Authors: JANE E. BRODY Tags: Drugs (Pharmaceuticals) Gabapentin (Drug) Opioids and Opiates Neurontin (Drug) Drug Abuse and Traffic Pain-Relieving Drugs Source Type: news
Extended-release Gabapentin for Failed Back Surgery Syndrome Extended-release Gabapentin for Failed Back Surgery Syndrome
Is extended-release gabapentin efficacious for persistent pain after lumbar surgery?Pain (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - May 16, 2019 Category: Orthopaedics Tags: Neurology & Neurosurgery Journal Article Source Type: news
